ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Chronic Low Back Pain

ClinicalTrials.gov ID: NCT04529096

Public ClinicalTrials.gov record NCT04529096. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 4:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Chronic Low Back Pain

Study identification

NCT ID
NCT04529096
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
149 participants

Conditions and interventions

Interventions

  • LY3016859 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 24, 2020
Primary completion
Jun 3, 2021
Completion
Oct 3, 2021
Last update posted
Nov 29, 2023

2020 – 2021

United States locations

U.S. sites
33
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Simon Williamson Clinic Birmingham Alabama 35211
Synexus - US Chandler Arizona 85224
Synexus- Chandler Chandler Arizona 85224
Irvine Clinical Research Center Irvine California 92614
Artemis Institute for Clinical Research Riverside California 92503
Artemis Institute for Clinical Research San Diego California 92103
VIN-Julie Schwartzbard Aventura Florida 33180
Suncoast Research Group Miami Florida 33135
Renstar Medical Research Ocala Florida 34470
Synexus - US Orlando Florida 32806
Synexus - US Pinellas Park Florida 33781
Martin E. Hale M.D., P.A. Plantation Florida 33317
Synexus - US The Villages Florida 32162
Synexus Clinical Research Chicago Illinois 60602
Northwestern University Chicago Illinois 60611
Cotton O'Neil Infusion Center Topeka Kansas 66606
ActivMed Practices and Research Methuen Massachusetts 01844
MedVadis Research Corporation Waltham Massachusetts 02451
Great Lakes Research Group, Inc. Bay City Michigan 48706
StudyMetrix Research City of Saint Peters Missouri 63303
Synexus - US Omaha Nebraska 68144
PharmQuest Greensboro North Carolina 27408
Synexus - Cincinnati Cincinnati Ohio 45236
Rapid Medical Research Cleveland Ohio 44122
Aventiv Research Inc Columbus Ohio 43213
Altoona Center For Clinical Research Duncansville Pennsylvania 16635
Clinical Research Center of Reading,LLC Wyomissing Pennsylvania 19610
Coastal Carolina Research Center North Charleston South Carolina 29405
Synexus - US Dallas Texas 75234
Synexus - San Antonio San Antonio Texas 78229
Synexus - US Murray Utah 84123
Northwest Clinical Research Center Bellevue Washington 98007-4209
Rainier Clinical Research Center Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04529096, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 29, 2023 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04529096 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →